Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Histochemistry|September 13, 1976
Fluorogenic detection of primary amines in plant histochemistry with fluorescamine: a comparative study on the effects of coagulant and non-coagulant fixativesA Bruni, M P Fasulo, B Tosi, et al.
Forensic Science International|May 19, 2009
Hair testing is superior to urine to disclose cocaine consumption in driver's licence regrantingM Polla, C Stramesi, S Pichini, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2020
ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors-A systematic review and meta-analysis of real world dataFilippo G Dall'Olio, Ilaria Maggio, Maria Massucci, et al.
Phytochemistry|July 25, 2009
Metabolites from in vitro cultures of Cassia didymobotryaG Delle Monache, M C De Rosa, R Scurria, et al.
Nature Reviews. Clinical Oncology|October 13, 2021
Tumour burden and efficacy of immune-checkpoint inhibitorsFilippo G Dall'Olio, Aurélien Marabelle, Caroline Caramella, et al.
Therapeutic Advances in Medical Oncology|November 16, 2020
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitorsFilippo G Dall'Olio, Francesca Abbati, Francesco Facchinetti, et al.
Palliative Medicine|March 26, 2014
The 'surprise' question in advanced cancer patients: A prospective study among general practitionersMatteo Moroni, Donato Zocchi, Deborah Bolognesi, et al.
Acta Gastro-Enterologica Belgica|October 2, 2021
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: a case seriesS Brocchi, A Parmeggiani, C Gaudiano, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2021
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumabFilippo G Dall'Olio, Diletta Calabrò, Nicole Conci, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2020
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients - A single centre experienceFilippo G Dall'Olio, Nicole Conci, Giulio Rossi, et al.
Pageof 5